Results
1483
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,483 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ONON | US$43.46 | 7.1% | 45.4% | US$13.4b | US$45.66 | PE76.9x | E24.7% | n/a | Consumer Durables | ||
AESI | US$20.17 | 3.3% | -8.7% | US$2.2b | US$26.33 | PE15.2x | E42.7% | 4.6% | Energy | ||
LAVV3 | R$8.64 | -2.2% | -2.0% | R$1.7b | R$12.90 | PE6.2x | E21.2% | 3.3% | Real Estate Management and Development | ||
CRDO | US$36.08 | 18.9% | 142.5% | US$6.0b | US$32.17 | PS30.9x | E60.9% | n/a | Semiconductors | ||
EH | US$12.47 | 3.6% | -32.0% | US$763.9m | US$24.98 | PS35.9x | E74.9% | n/a | Capital Goods | ||
CTT | AU$1.46 | 13.2% | -48.4% | AU$594.7m | AU$3.12 | PE28.7x | E26.7% | n/a | Retail | ||
A067310 | ₩14,030.00 | -8.6% | -17.4% | ₩725.5b | ₩24,347.83 | PB2.5x | E97.4% | 0.3% | Semiconductors | ||
GIG | NOK 29.95 | 0.2% | 0.3% | NOK 4.0b | NOK 45.03 | PE18.7x | E37.4% | n/a | Consumer Services | ||
VOW | NOK 6.72 | -4.0% | -47.4% | NOK 765.0m | NOK 11.00 | PB1.9x | E97.7% | 0% | Commercial Services | ||
A204620 | ₩3,820.00 | -7.8% | -33.0% | ₩216.9b | ₩7,233.33 | PS2x | E78.5% | n/a | Commercial Services | ||
YGG | ฿0.90 | 8.4% | -88.2% | ฿541.8m | ฿10.75 | PS1.9x | E85.5% | 29.8% | Media | ||
688408 | CN¥54.52 | -3.0% | 45.2% | CN¥10.9b | CN¥68.64 | PE23.8x | E26.9% | 1.1% | Capital Goods | ||
A179900 | ₩25,300.00 | -6.8% | 11.9% | ₩400.3b | ₩60,000.00 | PS19.9x | E122.7% | 0% | Tech | ||
AV1 | AU$0.058 | 0% | 31.8% | AU$45.7m | n/a | PS14.1x | E103.9% | n/a | Software | ||
A178320 | ₩27,350.00 | -0.4% | 71.9% | ₩1.5t | ₩39,333.33 | PE142.3x | E62.1% | 0% | Tech | ||
ACI | ₹821.00 | 14.6% | 41.1% | ₹101.3b | ₹832.17 | PE37.5x | E35.0% | 0.4% | Materials | ||
CALTX | SEK 206.80 | 0.1% | 119.9% | SEK 11.2b | SEK 227.50 | PS7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
A137400 | ₩55,200.00 | -4.5% | -15.9% | ₩1.3t | ₩85,350.00 | PE14x | E35.6% | 0% | Capital Goods | ||
4480 | JP¥3,340.00 | 8.3% | -37.5% | JP¥108.5b | JP¥5,650.00 | PE40.3x | E30.5% | n/a | Healthcare | ||
CUV | AU$13.19 | -5.5% | -38.0% | AU$660.5m | AU$29.22 | PE21.9x | E27.0% | 0.4% | Pharmaceuticals & Biotech | ||
505283 | ₹1,323.30 | 5.9% | 103.6% | ₹85.8b | ₹1,706.50 | PE60.3x | E30.1% | 0.5% | Capital Goods | ||
ADOC | €5.66 | -8.1% | -55.5% | €85.1m | €6.30 | PS14.1x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
PLT | AU$0.70 | 0.7% | 95.8% | AU$123.6m | AU$1.30 | PS1.7x | E106.4% | n/a | Diversified Financials | ||
KEBNI B | SEK 1.37 | -8.4% | 2.2% | SEK 370.4m | SEK 2.20 | PS3.2x | E86.1% | n/a | Tech |